![](https://investorshub.advfn.com/uicon/73566.png?cb=1512220552)
Tuesday, May 15, 2012 7:28:30 PM
Second, the sales will increase the value of ARNA. This is enticing to other companies for any possible buy out, or if the drug is not approved for whatever reason the company will not tank because of it. ARNA could basically settle any debts, and look very favorable to a suitor.
If you check out http://www.eisai.com/news/news201224.html EISAI is also doing something interesting not sure what......
Either way, when you bought into this company, you invested your DD and time and money, for a return. I still believe that ARNA will be successful on 6-27. We may only see 18-20 dollars instead of 22-25 dollars, who knows. I personally will be taking advantage of these cheap shares.....glty
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM